U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457437) titled 'Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment' on Feb. 19.
Brief Summary: This study aims to investigate the effect that a structured, progressive resistance exercise program may have on maintaining the muscle mass and physical function of overweight/ obese females whilst they experience a tirzepatide (GLP-1/GIP receptor agonist) induced weight loss.
Overweight and obese females aged 25-50 will be recruited for the study, they will require a BMI of >30 or >27 with one obesity related comorbidity (excluding diabetes). They will be screened, prescribed tirzepatide and then randomly assigned ...